Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer
NCT ID: NCT04389424
Last Updated: 2020-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2017-09-01
2022-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment
NCT03625635
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
NCT00316836
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
NCT06361940
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
NCT04666805
Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy
NCT06623903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anastrozole
Breast cancer women with anastrozole treatment
Anastrozole
Use of anastrozole for breast cancer recurrence prevention
Tamoxifen
Breast cancer women with tamoxifen treatment
Tamoxifen
Use of tamoxifen for breast cancer recurrence prevention
Exemestane
Breast cancer women with exemestane treatment
Exemestane
Use of exemestane for breast cancer recurrence prevention
Basal
Breast cancer women luminal type without any endocrine treatment (at initial diagnosis)
Basal
Initial diagnosis of breast cacner by biopsy or mastectomy
Recurrence
Breast cancer women luminal type with recurrence of disease during endocrine therapy
Tamoxifen
Use of tamoxifen for breast cancer recurrence prevention
Anastrozole
Use of anastrozole for breast cancer recurrence prevention
Recurrence
Breast cancer recurrence under endocrine therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tamoxifen
Use of tamoxifen for breast cancer recurrence prevention
Exemestane
Use of exemestane for breast cancer recurrence prevention
Anastrozole
Use of anastrozole for breast cancer recurrence prevention
Basal
Initial diagnosis of breast cacner by biopsy or mastectomy
Recurrence
Breast cancer recurrence under endocrine therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed consent
Exclusion Criteria
18 Years
98 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Guadalajara
OTHER
Instituto Jalisciense de Cancerologia
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Jalisciense de Cancerologia
Guadalajara, Jalisco, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Instituto Jalisciense de Cancerología
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.